MedTrace Logo

Risk Stratification in Patients With Preserved Ejection Fraction

NCT02124018 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 575

Last updated 2019-09-04

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to assess the prevalence and the prognostic value of non-invasive indexes and programmed ventricular stimulation for sudden cardiac death in post-myocardial infarction (MI) patients with left ventricular ejection fraction (LVEF)\>40%.

Conditions

Interventions

PROCEDURE

Programmed ventricular stimulation

Programmed ventricular stimulation in high-risk patients based on non-invasive evaluation

DEVICE

ICD implantation

ICD implantation in patients with induced VT in programmed ventricular stimulation

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • General Electric

    collaborator INDUSTRY

  • University of Athens

    lead OTHER

Principal Investigators

  • Konstantinos Gatzoulis, MD, PhD · University of Athens, Hippokration Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-01
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02124018 on ClinicalTrials.gov